Founder and Clinical Leader, Neurovana | Board-certified Family Nurse Practitioner specializing in psychiatry, 10+ years treating insomnia, anxiety, and complex psychiatric cases
A patient I see regularly came to me two years ago. She had been on a low dose benzodiazepine for sleep since her divorce. It helped her fall asleep. What it did not do was keep her asleep. She still woke at 2am most nights, lay there for an hour or two, then drifted back into shallow sleep before her alarm. Her primary care provider mentioned increasing the dose. She did not want to.
She asked me the same question I hear often: "Is there anything else?"
There is. It has over 160 published human studies behind it, a 45 year FDA regulatory track record, and a head to head clinical trial against a commonly prescribed sleep medication where it came out ahead. Most patients have never heard of it.
That tool is cranial electrotherapy stimulation, or CES therapy. For patients looking for insomnia treatment without medication, or those who want to reduce their reliance on sleep drugs, the evidence behind CES is worth understanding. This article covers what that evidence actually shows. I want to give you the honest version, not the marketing version.
Key Takeaways:
-
CES therapy is FDA-cleared for insomnia and has been studied since the 1970s
-
A 2019 RCT found CES superior to clonazepam for sleep quality and anxiety over 12 weeks
-
CES regulates nervous system activity. It does not chemically sedate the brain
-
About two-thirds of patients respond, within 4 to 8 weeks of daily use
-
CES requires a prescription.
Why Insomnia Is Harder to Treat Than Most People Expect
The difference between falling asleep and staying asleep
Insomnia treatment works differently depending on the type. For many, chronic insomnia is not 'I cannot fall asleep.' It is 'I fall asleep fine and then wake at 2 or 3am and my brain will not stop.'
This is sleep maintenance insomnia. It is a common pattern I see in clinical practice. It matters because many standard sleep medications help people fall asleep better than they help them stay asleep. They fix one part of the problem and leave the other untouched.
Sleep maintenance insomnia is often driven by nervous system hyperarousal. The brain stress circuits stay partly active even during sleep. Cortisol levels spike early in the morning, earlier than they should. This pulls the person out of deep sleep and into anxious wakefulness. The nervous system, stuck in a chronic active state, cannot fully wind down. Good sleep hygiene will not fix that. Neither will willpower.
Why sleep hygiene alone rarely fixes chronic insomnia
Sleep hygiene matters as a foundation. Keep a consistent sleep schedule. Cut caffeine after noon. Limit screens before bed. These are genuinely helpful for preventing insomnia from taking hold.
But once chronic insomnia is set, three or more months of disrupted sleep, sleep hygiene alone rarely reverses it. The nervous system has learned the pattern. Lying in bed now feels tied to wakefulness and frustration rather than rest. The bedroom itself becomes a cue for alertness.
Sleep hygiene is excellent maintenance. It keeps the engine running smoothly. It does not rebuild the engine once something has broken.
The nervous system piece most treatments miss
Cognitive behavioral therapy for insomnia, or CBT-I, is the first-line treatment for chronic insomnia. It works. It targets the learned behaviors and thought patterns that keep the insomnia cycle going, and its effects tend to last longer than medication effects.
The challenge is access. There are not enough trained CBT-I providers to meet demand. It takes weeks of consistent effort. And for patients whose insomnia is rooted in persistent nervous system dysregulation, chronic cortisol elevation and ongoing sympathetic overdrive, behavioral work alone sometimes cannot shift the underlying biology.
This is the gap where CES therapy shows the most consistent evidence.
What the Research Actually Shows for CES and Insomnia
The head-to-head trial: CES vs. a sleep medication
In 2019, researchers at the First Affiliated Hospital of Chongqing Medical University published a randomized controlled trial comparing CES directly to clonazepam, a benzodiazepine prescribed for insomnia, in elderly patients with chronic sleep disorders (Ren et al., 2019, Chinese Journal of Modern Nursing).
The study enrolled 120 patients. Half received 12 weeks of daily 20-minute CES sessions. Half received standard medication. Sleep quality and anxiety were assessed at baseline and at 12 weeks using the Pittsburgh Sleep Quality Index (PSQI) and the Hamilton Anxiety Rating Scale (HAM-A).
At the end of the trial, the CES group showed superior outcomes on both measures. Not equivalent. Superior.
I want to be careful about how I frame this. It does not mean CES is better than all sleeping pills for all patients. What it means is that in this population, over 12 weeks, CES matched and then exceeded the results of a prescribed benzodiazepine on the specific outcomes the study measured. That is a finding worth knowing about.
What the broader evidence base shows
CES has over 160 published human studies behind it since the 1970s (Gilula and Kirsch, 2005). A meta-analysis of 14 randomized controlled trials found a mean effect size of d=0.62 (Klawansky et al., 1995), a clinically meaningful result. A 2022 meta-analysis found a large treatment effect for insomnia outcomes with a standardized mean difference of negative 1.02 across three trials (p=0.0006). CES devices have been FDA-cleared for insomnia since 1979, a 45 year regulatory track record.
What CES cannot do
This is where I need to be honest with you.
CES works for about two-thirds of insomnia patients who try it. One-third do not respond. It is not a cure. It does not work overnight or in one session. And it is not right for every patient with insomnia.
If you have untreated sleep apnea, CES does not fix airway obstruction. If your insomnia is clearly driven by a medication side effect, address the medication first. If you are in acute psychiatric crisis, CES is not a crisis tool.
There are also groups where I suggest an extra conversation with your provider before starting. Patients with implanted electrical devices such as pacemakers, ICDs, or deep brain stimulators should consult both their Neurovana provider and the physician managing their device. Pregnant patients should discuss CES with their provider before starting, out of standard caution, even though no documented harm has ever occurred
This is not a device that works for everyone. Nothing is. But for the right patient, the evidence is real.
How CES Works and Why It Differs From a Sleeping Pill
What sleeping pills actually do
Benzodiazepines like clonazepam and diazepam, and non-benzo Z-drugs like zolpidem and eszopiclone, work by boosting GABA activity in the brain. GABA is the brain's main inhibitory signal. More GABA means more sedation. You fall asleep faster and often stay asleep longer in the short term.
The problems with ongoing use are well documented. Tolerance develops. Rebound insomnia is common when the drug is stopped, because the brain has grown used to the external GABA boost and cannot wind down on its own. Dependency risk is real, especially with benzodiazepines. Next day grogginess, memory gaps, and slowed reactions are consistent complaints.
These medications work for many patients and have a real place in treatment. I prescribe them when the situation calls for it. But short-term results and the best answer for ongoing use are different questions.
What CES does instead
CES delivers low amplitude microcurrent through earlobe clip electrodes at 100 Hz. The current runs between 50 and 600 microamperes. That is roughly one thousandth the strength used in ECT. Most patients feel a mild tingling at the electrode sites and nothing more.
Rather than boosting GABA to force sedation, CES recalibrates the brain's baseline activity. fMRI research shows CES produces measurable changes in brain regions linked to hyperarousal: the posterior cingulate cortex, the precuneus, and the supplementary motor area (Feusner et al., 2012, Brain and Behavior). These are the same regions that stay overactive in people with chronic insomnia. The goal is not to knock the brain offline. It is to help the brain find its way back to a calmer state on its own.
Neurovana's devices run at 100 Hz because the evidence supports it. Research comparing 100 Hz and 0.5 Hz CES found that 100 Hz produced greater overall changes in brain electrical activity, with EEG patterns resembling relaxation states seen in trained meditators (Schroeder and Barr, 2001, Clinical Neurophysiology).
Side effects and tolerability
The tolerability profile of CES is one of its most notable clinical features.
The Barclay and Barclay (2014) randomized double blind sham controlled trial reported zero adverse events in 115 participants over five weeks. A small number of patients experience mild tingling at the electrode sites, and some report a mild headache in the first few sessions. But there is no dependency, no withdrawal, no rebound insomnia, and no next day cognitive fog.
For a patient who has been managing insomnia for years and worries about adding another dependency, this profile matters.
Who Is a Good Candidate for CES Therapy for Insomnia
The patients I see respond best
In my clinical experience, patients who respond most consistently to CES for insomnia share a few features. They have moderate to severe chronic insomnia lasting three or more months. Their insomnia has a clear anxiety or hyperarousal component. They may have tried CBT-I with partial success, or they cannot access a trained provider.
Patients who want to reduce or stop benzodiazepine use are often strong candidates. CES does not require tapering, creates no dependency, and can support the nervous system during a slow medication wean. Midlife patients whose insomnia worsened during perimenopause are another common group.
CES pairs well with behavioral sleep therapy rather than replacing it. Behavioral therapy addresses learned patterns. CES addresses the underlying biology. Together they tend to produce better results than either approach alone.
Who should look at other options first
If you have obstructive sleep apnea that has not been treated, start there. No nervous system work will compensate for fragmented sleep driven by airway blockage. If your sleep trouble is a direct side effect of a medication you are taking for another condition, work with your prescribing provider on that first.
Patients new to treatment should generally start with CBT-I. CES is most useful for those who have tried the behavioral route and still need more support, or who are managing ongoing anxiety that behavioral work does not fully resolve. You can read more about how anxiety and nervous system dysregulation connect to disrupted sleep and what actually changes the nervous system's baseline.
What to Expect if You Start CES for Insomnia
How sessions work
A standard CES session runs 30 to 45 minutes. You clip the electrodes to your earlobes, set the device, and go about your morning or sit quietly. The current is below the threshold of sensation for most patients, or produces a very mild tingling. There is no discomfort.
Most patients use CES in the morning or early afternoon. A smaller group finds that using it too close to sleep creates a mild alerting effect, in which case morning use works better. Your prescribing provider will help you dial in timing based on how you respond.
My colleague Tyson Flower, FNP-C and our Chief Medical Officer, told me he had not remembered his dreams in nearly a decade before he started using CES himself. After about a week of daily sessions, dream recall returned. His words: 'Something was changing at a neurological level.' That observation meant something to me.
The timeline for results
Most patients who respond to CES for insomnia see meaningful sleep improvement within 4 to 8 weeks of consistent daily use. Some respond faster. Others need more time, especially with longstanding insomnia.
One or two sessions is not a fair test. The mechanism is cumulative. A 4 week minimum trial is needed to fairly assess whether CES is working for you.
How CES fits into a structured program
CES therapy works best when prescribed and monitored by a clinician who can track your response, adjust timing, and combine it with appropriate support. The Neurovana clinical program ncludes frequent follow-up visits within the first 3 months of use, with validated outcome measures, such as the ISI or PSQI.
If you are exploring whether CES fits your situation, start with a clinician who prescribes it. You can learn more about the Neurovana Calm Ultra and its clinical specs to bring specific questions to that conversation.
CES vs. Sleeping Pills: An Honest Comparison
Neither option works for everyone. The right choice depends on the patient, severity and duration of insomnia, other conditions, and provider judgment.
| Sleeping Pills (benzos / Z-drugs) | CES Therapy | |
|---|---|---|
| Mechanism | GABA boost leading to sedation | Nervous system recalibration |
| Onset | Same night | 4 to 8 weeks, cumulative |
| Dependency risk | Yes, especially benzos | None reported |
| Rebound insomnia | Common on stopping | Not reported |
| Side effects | Next-day sedation, memory effects | Mild tingling, headache (very rare) |
| Ongoing use | Tolerance develops | Safe for ongoing use |
| Response rate | Varies by drug and patient | About two-thirds of patients |
| Prescription needed | Yes | Yes, through Neurovana |
Neurovana is not anti-medication. It is pro-options. Patients who need more tools deserve to know those tools exist.
Frequently Asked Questions About CES Therapy for Insomnia
Is CES therapy FDA-cleared for insomnia?
Yes. CES devices have been FDA-cleared for insomnia since 1979. The Neurovana Calm Ultra is FDA-cleared for both anxiety and insomnia.
How long does it take for CES to work for insomnia?
Most patients who respond see meaningful sleep improvement within 4 to 8 weeks of consistent daily use. A minimum 4-week trial is needed. One or two sessions is not enough to judge.
Can I use CES therapy instead of sleeping pills?
For some patients, yes. This is especially true for those who want to reduce benzodiazepine use and whose insomnia has an anxiety or hyperarousal component. CES creates no dependency and causes no rebound insomnia on stopping. Any medication changes should happen gradually with provider guidance.
Is CES safe for ongoing use?
Current evidence supports ongoing use. CES does not require tapering when stopped. No withdrawal effect has been documented. It does not carry the tolerance or dependency risks of benzodiazepine use.
What is the difference between CES therapy and TMS or ECT?
TMS uses magnetic fields and requires in-office delivery. ECT uses high electrical current to produce a controlled seizure under anesthesia. CES uses microcurrent, roughly one thousandth the strength of ECT, delivered through earlobe electrodes at home. The mechanisms, uses, and risk profiles of all three are very different.
Can CES help with sleep maintenance and insomnia?
Yes. Sleep maintenance insomnia is often driven by nervous system hyperarousal and early cortisol surges. CES works on the nervous system's baseline activation level, targeting this mechanism more directly than sleep onset aids. The Ren et al. (2019) trial assessed sleep quality using the PSQI, which captures both sleep onset and sleep maintenance dimensions.
Do I need a prescription for CES therapy?
Yes, CES devices are available by prescription. CES is most effective as part of a supervised care plan.
The Bottom Line
CES therapy for insomnia is not new. It is not experimental. What it is, is underused. It carries 45 years of regulatory history and a genuine evidence base that most patients and many providers have never encountered.
It will not work for everyone. No treatment does. But for patients managing chronic insomnia, especially those with a concurrent anxiety component, those who have plateaued on behavioral work, or those who want to reduce their reliance on sleep medication, the evidence is worth taking seriously.
If you are exploring whether CES fits your situation, start with a clinician who prescribes it. You can review the clinical evidence for the Neurovana Calm Ultra and bring specific questions to that conversation.